Thomas Wessel
2016
In 2016, Thomas Wessel earned a total compensation of $874.4K as Chief Medical Officer at Flex Pharma, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $138,329 |
|---|---|
| Option Awards | $316,061 |
| Salary | $406,850 |
| Other | $13,187 |
| Total | $874,427 |
Wessel received $406.9K in salary, accounting for 47% of the total pay in 2016.
Wessel also received $138.3K in non-equity incentive plan, $316.1K in option awards and $13.2K in other compensation.
Rankings
In 2016, Thomas Wessel's compensation ranked 8,875th out of 14,075 executives tracked by ExecPay. In other words, Wessel earned more than 36.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,875 out of 14,075 | 37th |
Division Manufacturing | 3,436 out of 5,486 | 37th |
Major group Chemicals And Allied Products | 1,165 out of 1,900 | 39th |
Industry group Drugs | 918 out of 1,543 | 41st |
Industry Pharmaceutical Preparations | 731 out of 1,173 | 38th |
Source: SEC filing on April 19, 2017.
Wessel's colleagues
We found two more compensation records of executives who worked with Thomas Wessel at Flex Pharma in 2016.